A major breakthrough in cancer genetics has been achieved, paving the way for more effective prevention, early detection, and ...

SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor ...

Study results show that genetic sensitivity to stress was linked to a 49% higher risk of lung cancer in people of European ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

In a retrospective study of 265 patients with drug-resistant solid organ cancers, ‘Exacta AI’ provided at least seven therapy ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, ...

Every minute, 38 people are diagnosed with cancer, and 18 people die from it globally, according to the World Health ...

A person’s lifetime risk of cancer might be partly established before they are even born, a new mouse study says.Resear ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc. announced ...

"We have discovered a molecular switch that can revert the fate of cancer cells," said biologist Kwang-Hyun Cho.

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...